Cargando…
Should molecular subtype be recommended as one of the selection criteria for accelerated partial breast irradiation? Preliminary results from an Asian cohort
PURPOSE: The purpose of this study was to report clinical outcomes in patients treated with accelerated partial breast irradiation (APBI), stratified as per molecular subtype and American Society for Therapeutic Radiology and Oncology/Groupe Européen de Curiethérapie and European Society for Radioth...
Autores principales: | Wadasadawala, Tabassum, Mondal, Monidipa, Paul, Siji Nojin, Parmar, Vani, Nair, Nita, Shet, Tanuja, Desai, Sangeeta, Gupta, Sudeep, Sarin, Rajiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881594/ https://www.ncbi.nlm.nih.gov/pubmed/29619056 http://dx.doi.org/10.5114/jcb.2018.74137 |
Ejemplares similares
-
Pilomatrix Carcinoma Masquerading as Breast Carcinoma
por: Pai, Trupti, et al.
Publicado: (2017) -
Multi-catheter interstitial brachytherapy for partial breast irradiation: an audit of implant quality based on dosimetric evaluation comparing intra-operative versus post-operative placement
por: Gurram, Lavanya, et al.
Publicado: (2016) -
Long-term outcomes and prognostic factors in elderly patients with breast cancer: single-institutional experience
por: Wadasadawala, Tabassum, et al.
Publicado: (2023) -
Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort
por: Bajpai, Jyoti, et al.
Publicado: (2022) -
Breast cancer: An overview of published Indian data
por: Rangarajan, Bharath, et al.
Publicado: (2016)